Anti-cancer Medicine
Diagnostics
Palliative Care
Palliative
Care
Cancer
Patient
Anti-cancer Medicine
Doctors

Products
& Pipeline

Cannabics is developing diagnostic procedures designated for delivering precise data regarding the individual patients treatment choices for treating cancer and its side-effects . We are currently engaged in a clinical study, in Israel, on Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients. Our path to fight cancer is based on the engagement with technology tools such as High Throughput Screening Technology (HTS)  on cancer cell lines and CTC drug sensitivity tests on liquid biopsies.

PRE-CLINIC
CLINICAL STUDY
MARKET
PALLIATIVE TREATMENT
PRE-CLINIC
checked
CLINICAL STUDY
ONGOING
MARKET
checked
ONGOING
DIAGNOSTICS
PRE-CLINIC
checked
CLINICAL STUDY
MARKET
checked
checked
checked
GENETICS
PRE-CLINIC
checked
CLINICAL STUDY
MARKET
checked

TEAM

Co-founder & CEO

Environmentalist with vast experience in the medical cannabis field.
Mr. Borochov started his first cannabis venture in 2008.
Itamar brings vast experience in the areas of market intelligence and strategy.

X
Co-founder & CTO

Holds a Ph.D. in Neurophysiology, Brain Waves and Cortical Connectivity in Attention. After obtaining his Ph.D. he was an entrepreneur in the field of neurofeedback and developed “Luna Mind” – recreational brain-computer interfaces. Dr. Ballan holds an M.Sc. from Tel-Aviv University – Magna Cum Laude – in molecular biology and anticancer drug development. Dr. Ballan was part of the research team which developed Salirasib (Treatment for Non-Small Cell Lung Cancer).
Since 2005 Eyal has been teaching the “Second Attention”- Neuro-Phisological aspects of Higher Perception and Cognition.

X

Has over 20 years of broad experience in
corporate finance, accounting, M&A transactions, IPO’s and operations. Mr. Ben-Or is CEO & Founder of one of the few financial firms in Israel to have the International Standard on Assurance Engagement (ISAE 3402/SAS 70 Type II) assurance with control compliances, the new global standard for assurance reporting. He previously served as an Auditor at PricewaterhouseCoopers Accounting Firm.
Mr. Ben-Or holds a BA degree in Business from the College of Administration, an MBA degree from the Bar Ilan University and is a Certified Public Accountant.

X
Co-Founder

Core member of Cannabics’s management team. Eyal has a BA in Economics & International
Relations from the Hebrew University in Jerusalem and an MBA with Honors from Haifa University

X
Secretary, Corporate Counsel

Took the company public on the US exchange and is a native Washingtonian. David brings a dynamic and
varied background, having worked in the Diplomatic Corps in the Israeli Foreign Office as well as
a Congressional Aide in the US Congress, and General Counsel to consultants at the World Bank as well as the IDB, EX-IM and IMF in Washington, DC. He has a BA in International Relations from the University of Maryland, and JD from Antioch DC School of Law.

X

Mr. Itamar Borochov

Co-founder & CEO

Itamar is an environmentalist with vast experience as an entrepreneur in the fields of organic and ecologically-oriented agriculture, medicinal herbs and medical cannabis.

Dr. Eyal Ballan

Co-founder & CTO

Holds a Ph.D. in Neurophysiology, Brain Waves and Cortical Connectivity in Attention. After obtaining his Ph.D. he was an entrepreneur in the field of neurofeedback and developed “Luna Mind” – recreational brain-computer interfaces. Dr. Ballan holds an M.Sc. from Tel-Aviv University – Magna Cum Laude – in molecular biology and anticancer drug development. Dr. Ballan was part of the research team which developed Salirasib (Treatment for Non-Small Cell Lung Cancer).
Since 2005 Eyal has been teaching the “Second Attention”- Neuro-Physiological aspects of Higher Perception and Cognition.

Dr. Moran Grinberg

VP of R&D

Dr. Moran Grinberg has vast experience in the Research and Development field. Dr. Grinberg’s uniqueness is her ability of
transferring new technologies from bench to bedside, For the last 5 years she led and managed top pharmaceutical and microbiological projects in start-up companies. Moran Grinberg has a BSc in Biochemistry and PhD cum laude in Microbiology and Immunology and MSc cum laude in Endocrinology – Ben Gurion University, Beersheva, Israel.

Uri Ben-Or

CFO

Has over 20 years of broad experience in
corporate finance, accounting, M&A transactions, IPO’s and operations. Mr. Ben-Or is CEO & Founder of one of the few financial firms in Israel to have the International Standard on Assurance Engagement (ISAE 3402/SAS 70 Type II) assurance with control compliances, the new global standard for assurance reporting. He previously served as an Auditor at PricewaterhouseCoopers Accounting Firm.
Mr. Ben-Or holds a BA degree in Business from the College of Administration, an MBA degree from the Bar Ilan University and is a Certified Public Accountant.

David E. Price, Esq

Secretary, Corporate Counsel

Took the company public on the US exchange and is a native Washingtonian. David brings a dynamic and
varied background, having worked in the Diplomatic Corps in the Israeli Foreign Office as well as
a Congressional Aide in the US Congress, and General Counsel to consultants at the World Bank as well as the IDB, EX-IM and IMF in Washington, DC. He has a BA in International Relations from the University of Maryland, and JD from Antioch DC School of Law.

Eyal Barad

Co-Founder

Core member of Cannabics’s management team. Eyal has a BA in Economics & International
Relations from the Hebrew University in Jerusalem and an MBA with Honors from Haifa University

Prof. Amos Toren, MD

Medical Advisor

Prof. Amos Toren is the Director of Pediatric Hemato-Oncology and BMT Department at the Sheba Medical Center since 2001 and a Professor in the division of Hematology, Sackler School of Medicine Tel-Aviv University. Prof. Toren is a specialist in Pediatrics, General Hematology and Pediatric Hemato-Oncology. He also has a PhD degree in genetics and qualified as a Master of Health Administration (MHA) at the Recannati Business School, Tel-Aviv University. Professor Toren runs numerous clinical studies, investigator initiated, company initiated, unicenter as well as multicenter.

Dr. Martin Burow

Scientific Advisor

Dr. Martin Burow is the founder and owner of DMB-Diagnostics GmbH and a specialist at medical sales and marketing activities in Asia and Europe. Dr. Burow specializes in the development and sale of devices for diagnostic analysis and diagnostic markers. Dr. Burow holds a Phd in BioChemistry from the University of Münster.

Dr. Tal Mofkadi

Financial Advisor

Dr. Mofkadi holds a Ph.D in Financial Economics from Tel Aviv University. He is a lecturer at Tel Aviv University, the Interdisciplinary Center in Herzliya and universities abroad. He is the author of ‘The Handbook of Corporate Valuation’. Dr. Mofkadi provides expert opinions in financing, economic, and legal proceedings, writing valuations and optimal pricing policies as well as economic analysis of competition and regulatory aspects, risk assessment and more.

Dr. Sigalit Ariely-Portnoy

Strategic Regulatory Advisor, Clinical, Quality and Validation

Dr. Sigalit Ariely-Portnoy has vast experience in the pharmaceutical industry and managed pharmaceutical and chemical plants at Taro pharmaceutical industries Ltd as Operation Group Vice President and in Teva Pharmaceutical Industries Ltd as OSD plant manager. In the last 7 years, Sigalit is the CEO of Gsap, the largest consulting company for pharmaceutical and medical device companies in Israel. Sigalit Ariely-Portnoy has a BSc and PhD in Chemical Engineering and MSc in Bio-Medical Engineering from the Technion – Israel Institute of Technology, Haifa, Israel.

Dr. Gil Feiler

Head of Advisory Board and Business Development Advisor

Dr. Feiler is a banker and hedge fund manager. Dr. Feiler served as Board Member of Advanced Vision Technology, traded on the Frankfurt Stock Exchange (VSJ), served on the Board of Safra Bank Mutual Fund Division; and has served as Administrative advisor for the Government of Ras Al Khaimah, UAE. Dr. Feiler has published extensively on business opportunities and strategies and was a frequent speaker in world events including the World Economic Forum in Davos.